Deauville five-point scale
A 1-to-5 score for how bright a lymphoma looks on PET compared with the liver; 1-3 is considered a complete metabolic response.
1: no uptake; 2: ≤ mediastinum; 3: > mediastinum but ≤ liver; 4: moderately > liver; 5: markedly > liver or new lesions. Adopted in the Lugano classification (2014); the decision point in PET-adapted Hodgkin and DLBCL trials. Inter-reader agreement is good at the extremes and weaker for score 3 vs 4.
Pages like this
not linked directly; found by shared links- PairingCaution: bleomycin lung toxicity, especially with brentuximab or G-CSF
Shares RATHL, PET-adapted (response-adapted) therapy, Hodgkin lymphoma.
- TermLugano classification / Ann Arbor staging
Shares FDG PET, Follicular lymphoma, Hodgkin lymphoma, Diffuse large B-cell lymphoma.
- CollectionLymphoma Research Foundation (LRF)
Shares Follicular lymphoma, Hodgkin lymphoma, Diffuse large B-cell lymphoma.
- TrialAHOD2131 (COG / NCTN)
Shares PET-adapted (response-adapted) therapy, Hodgkin lymphoma.
- IdeaChemotherapy-free Hodgkin lymphoma: brentuximab + PD-1 in early stage
Shares PET-adapted (response-adapted) therapy, Hodgkin lymphoma.
- InstitutionUniversity Hospital Southampton / Centre for Cancer Immunology
Shares FDG PET, Hodgkin lymphoma, Diffuse large B-cell lymphoma.
- CollectionLeukemia & Lymphoma Society (LLS)
Shares Follicular lymphoma, Hodgkin lymphoma, Diffuse large B-cell lymphoma.
- TrialGHSG HD21
Shares PET-adapted (response-adapted) therapy, Hodgkin lymphoma.